Table 4.
Moderate MDD | Severe MDD | Psychotic MDD | Overall: X2(2,43,868) |
Moderate vs. severe: X2(1,38,278) |
Moderate vs. psychotic: X2(1,17,906) |
Severe vs. psychotic: X2(1,31,552) |
||
---|---|---|---|---|---|---|---|---|
ADD monotherapy | Any | 23.2% | 17.1% | 4.4% | 954.9, p < 0.001, V = 0.10 | 201.5, p < 0.001, ϕ = 0.07 | 948.5, p < 0.001, ϕ = 0.23 | 586.7, p < 0.001, ϕ = 0.14 |
SSRI | 9.3% | 6.1% | 1.5% | 400.1, p < 0.001, V = 0.07 | 129.2, p < 0.001, ϕ = 0.06 | 36,594, p < 0.001, ϕ = 0.14 | 194.4, p < 0.001, ϕ = 0.08 | |
NaSSA | 5.3% | 4.3% | 1.2% | 163.2, p < 0.001, V = 0.04 | 18.9, p < 0.001, ϕ = 0.02 | 167.5, p < 0.001, ϕ = 0.10 | 122.4, p < 0.001, ϕ = 0.06 | |
SSNRI | 5.0% | 3.7% | 0.8% | 190.6, p < 0.001, V = 0.05 | 35.8, p < 0.001, ϕ = 0.03 | 190.9, p < 0.001, ϕ = 0.10 | 125.4, p < 0.001, ϕ = 0.06 | |
TCA | 1.4% | 1.7% | 0.1% | 84.6, p < 0.001, V = 0.03 | 4.8, p < 0.05, ϕ = 0.01 | 66.0, p < 0.001, ϕ = 0.06 | 84.3, p < 0.001, ϕ = 0.05 | |
APD monotherapy | 1.9% | 1.8% | 3.1% | 40.6, p < 0.001, V = 0.02 | 0.5, p = 0.50, ϕ < 0.01 | 24.9, p < 0.001, ϕ = 0.04 | 39.1, p < 0.001, ϕ = 0.04 | |
Number of psychotropic drugs per patient | > 2 | 35.5% | 46.3% | 66.6% | ||||
2 | 31.0% | 30.2% | 24.3% | |||||
1 | 26.9% | 20.0% | 7.8% | |||||
0 | 6.6% | 3.5% | 1.3% | |||||
Mean number of psychotropic drugs | 2.2 ± 1.3 | 2.5 ± 1.4 | 3.1 ± 1.3 | 949.3, p < 0.001, η2 = 0.041 | p < 0.001, η2 = 0.013 | p < 0.001, η2 = 0.041 | p < 0.001, η2 = 0.019 | |
Mean number of ADDs | 1.1 ± 0.7 | 1.2 ± 0.6 | 1.1 ± 0.6 | 66.5, p < 0.001 V < 0.001, η2 = 0.003 | p < 0.001, η2 = 0.001 | p = 0.42, η2 < 0.001 | p < 0.001, η2 = 0.001 | |
Mean number of APDs | 0.4 ± 0.6 | 0.6 ± 0.7 | 1.1 ± 0.7 | 2003.2, p < 0.001, η2 = 0.084 | p < 0.001, η2 = 0.010 | p < 0.001, η2 = 0.084 | p < 0.001, η2 = 0.060 |